Gansu Longshenrongfa Pharmaceutical Industry Co Ltd - Asset Resilience Ratio

Latest as of September 2023: -8.30%

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has an Asset Resilience Ratio of -8.30% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥-109.82 Million

≈ $-16.07 Million USD Cash + Short-term Investments

Total Assets

CN¥1.32 Billion

≈ $193.66 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's Asset Resilience Ratio has changed over time. Check 300534 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Gansu Longshenrongfa Pharmaceutical Indu market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-109.82 Million	-8.3%
Total Liquid Assets	CN¥-109.82 Million	-8.30%

Asset Resilience Insights

Limited Liquidity: Gansu Longshenrongfa Pharmaceutical Industry Co Ltd maintains only -8.30% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Industry Peers by Asset Resilience Ratio

Compare Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Almirall S.A. MC:ALM	Drug Manufacturers - Specialty & Generic	0.01%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	Drug Manufacturers - Specialty & Generic	-2.56%
ANI Pharmaceuticals Inc NASDAQ:ANIP	Drug Manufacturers - Specialty & Generic	0.63%
Beijing Winsunny Pharmaceutical CO.LTD SHG:601089	Drug Manufacturers - Specialty & Generic	10.89%
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (None–None)

The table below shows the annual Asset Resilience Ratio data for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

SHE:300534 China Drug Manufacturers - Specialty & Generic

Market Cap

$534.44 Million

CN¥3.65 Billion CNY

Market Cap Rank

#11644 Global

#3185 in China

Share Price

CN¥12.04

Change (1 day)

+20.04%

52-Week Range

CN¥6.95 - CN¥12.09

All Time High

CN¥29.78